Annexon appoints Jamie Dananberg as Chief Medical Officer

Annexon appointed Jamie Dananberg as Chief Medical Officer. Dananberg joins Annexon with more than 20 years of drug development experience across a variety of therapeutic areas in the pharmaceutical and biotechnology industries. Most recently, he served as chief medical officer for UNITY Biotechnology. Prior to UNITY, Dananberg served as executive vice president at Takeda Pharmaceuticals in several roles. Before joining Takeda, he spent 16 years at Eli Lilly & Co.